BioCentury | Jun 20, 2013
Cover Story

Interfacing with Ras

...pancreatic cancer. This is essentially an untreatable cancer-there is a huge unmet clinical need," added John Hancock...
...these mutants could be insensitive to small molecules that act via the GDP-bound conformation. Now, John Hancock...
BioCentury | Mar 26, 2007
Finance

Ebb & Flow

...and lead portfolio manager of its healthcare fund. Previously, he was a portfolio manager with John Hancock...
BioCentury | Dec 6, 2004
Company News

Charles River management update

...31; he will be replaced by Jody Acford, formerly SVP and deputy general counsel for John Hancock...
BioCentury | Mar 5, 2001
Finance

Ebb & Flow

...company CardiacAssist . John Hancock launched the John Hancock Biotechnology Fund to invest in biotech companies globally. John Hancock...
...$250 million. Linda Miller will manage the fund while continuing to oversee the $449 million John Hancock...
BioCentury | Mar 1, 2001
Financial News

John Hancock launches biotech fund

...John Hancock announced the formation of its John Hancock Biotechnology Fund, which will invest globally in biotech...
BioCentury | Sep 15, 2000
Financial News

Cubist raises $39 million

...Infectious disease company CBST sold $39 million of convertible notes to John Hancock Life Insurance to fund...
BioCentury | Mar 7, 2000
Financial News

Metabolex raises $10.75 million

...Hayward, Calif), which is developing glucose-lowering small molecules, sold a venture round to investors including John Hancock...
BioCentury | Feb 10, 2000
Top Story

Celgene raises $250.9 million

...and attention deficit hyperactivity (ADHD) in children. An additional 516,000 CELG shares were sold by John Hancock...
BioCentury | Feb 8, 2000
Financial News

Celgene ups stock offering

...its proposed stock offering from 2 million to 2.48 million shares with a 450,000-share overallotment. John Hancock...
BioCentury | Jan 19, 2000
Financial News

Celgene files for follow-on

...CELG plans to sell 2 million shares with a 362,400 share overallotment. John Hancock Mutual Life Insurance...
Items per page:
1 - 10 of 12
BioCentury | Jun 20, 2013
Cover Story

Interfacing with Ras

...pancreatic cancer. This is essentially an untreatable cancer-there is a huge unmet clinical need," added John Hancock...
...these mutants could be insensitive to small molecules that act via the GDP-bound conformation. Now, John Hancock...
BioCentury | Mar 26, 2007
Finance

Ebb & Flow

...and lead portfolio manager of its healthcare fund. Previously, he was a portfolio manager with John Hancock...
BioCentury | Dec 6, 2004
Company News

Charles River management update

...31; he will be replaced by Jody Acford, formerly SVP and deputy general counsel for John Hancock...
BioCentury | Mar 5, 2001
Finance

Ebb & Flow

...company CardiacAssist . John Hancock launched the John Hancock Biotechnology Fund to invest in biotech companies globally. John Hancock...
...$250 million. Linda Miller will manage the fund while continuing to oversee the $449 million John Hancock...
BioCentury | Mar 1, 2001
Financial News

John Hancock launches biotech fund

...John Hancock announced the formation of its John Hancock Biotechnology Fund, which will invest globally in biotech...
BioCentury | Sep 15, 2000
Financial News

Cubist raises $39 million

...Infectious disease company CBST sold $39 million of convertible notes to John Hancock Life Insurance to fund...
BioCentury | Mar 7, 2000
Financial News

Metabolex raises $10.75 million

...Hayward, Calif), which is developing glucose-lowering small molecules, sold a venture round to investors including John Hancock...
BioCentury | Feb 10, 2000
Top Story

Celgene raises $250.9 million

...and attention deficit hyperactivity (ADHD) in children. An additional 516,000 CELG shares were sold by John Hancock...
BioCentury | Feb 8, 2000
Financial News

Celgene ups stock offering

...its proposed stock offering from 2 million to 2.48 million shares with a 450,000-share overallotment. John Hancock...
BioCentury | Jan 19, 2000
Financial News

Celgene files for follow-on

...CELG plans to sell 2 million shares with a 362,400 share overallotment. John Hancock Mutual Life Insurance...
Items per page:
1 - 10 of 12